QQ客服 官方微博 反馈留言

	CTRP9 Ameliorates Pulmonary Arterial Hypertension Through Attenuating Inflammation and Improving Endothelial Cell Survival and Function.
	Li Yongxin; Geng Xigang; Wang Haichen; Cheng Gesheng; Xu Suochun
刊名	Journal of cardiovascular pharmacology
	2016
卷号	67期号:[db:dc_citation_issue]页码:394-401
ISSN号	1533-4023
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3226891
专题	西安交通大学
推荐引用方式 GB/T 7714	Li Yongxin,Geng Xigang,Wang Haichen,et al. CTRP9 Ameliorates Pulmonary Arterial Hypertension Through Attenuating Inflammation and Improving Endothelial Cell Survival and Function.[J]. Journal of cardiovascular pharmacology,2016,67([db:dc_citation_issue]):394-401.
APA	Li Yongxin,Geng Xigang,Wang Haichen,Cheng Gesheng,&Xu Suochun.(2016).CTRP9 Ameliorates Pulmonary Arterial Hypertension Through Attenuating Inflammation and Improving Endothelial Cell Survival and Function..Journal of cardiovascular pharmacology,67([db:dc_citation_issue]),394-401.
MLA	Li Yongxin,et al."CTRP9 Ameliorates Pulmonary Arterial Hypertension Through Attenuating Inflammation and Improving Endothelial Cell Survival and Function.".Journal of cardiovascular pharmacology 67.[db:dc_citation_issue](2016):394-401.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。